Cede del CNIO

Inicio | Acerca del CNIO | Portal de transparencia | Información institucional, organizativa y jurídica | Información organizativa | Comité Científico Asesor (Scientific Advisory Board)

Como órgano de apoyo y asesoramiento científico general existe un Comité Científico Asesor Externo, compuesto de científicos de especial relevancia  internacional en el campo de la investigación oncológica.

Son miembros del Comité Científico Asesor:

  • Mariann Bienz, PhD, FRS, FMedSci (Chair)
    Deputy Director, MRC Laboratoy of Molecular Biology
    Group Leader, LMB Division of Protein and Nucleic Acid Chemistry
    MRC Laboratory of Molecular Biology
    Cambridge, United Kingdom
  • Genevieve Almouzni, PhD
    Director of Research Exceptional Class, Centre National de la Recherche Scientifique
    Honorary Director of the Curie Institute Research Center,
    Team Leader, Nuclear Dynamics Research Unit
    Institut Curie, Paris, France
  • José Costa, MD, FACP
    Professor Emeritus of Pathology and Senior Research Scientist
    Yale University School of Medicine
    New Haven, USA
  • Sara Courtneidge, PhD, DSc (hc)
    Professor, Departments of Cell, Developmental and Cancer Biology and Biomedical Engineering, School of Medicine
    Member, Center for Spatial Systems Biomedicine
    Oregon Health & Science University
    Portland, USA
  • John F.X. Diffley, PhD
    Associate Research Director
    The Francis Crick Institute
    London, United Kingdom
  • Rosalind Eeles, PhD, FRCP, FRCR, FMedSci
    Professor of Oncogenetics, the Institute of Cancer Research
    Honorary Consultant in Cancer Genetics and Clinical Oncology
    The Royal Marsden NHS Foundation Trust
    Sutton, United Kingdom
  • Denise Galloway, PhD
    Scientific Director, Pathogen-Associated Malignancies Integrated Research Center
    Paul Stephanus Memorial Endowed Chair
    Fred Hutchinson Cancer Research Center
    Seattle, USA
  • E. Yvonne Jones, FRS, FMedSci
    Joint Head of the Division of Structural Biology, Nuffield Dept. of Clinical Medicine
    Deputy Director, the Wellcome Trust Centre for Human Genetics
    Director, Cancer Research UK Receptor Structure Group
    University of Oxford
    Oxford, United Kingdom
  • Scott W. Lowe, PhD
    Chair, Cancer Biology and Genetics Program, SKI
    Chair, Geoffrey Beene Cancer Research Center
    Memorial Sloan-Kettering Cancer Center
    New York, USA
  • Ángela Nieto, PhD
    Full Professor and Head of the Developmental Neurobiology Unit
    Neuroscience Institute of Alicante (CSIC-UMH)
    Alicante, Spain
  • Andre Nussenzweig, PhD
    Chief, Laboratory of Genome Integrity
    NIH Distinguished Investigator, Head of the Molecular Recombination Unit
    Center for Cancer Research, National Cancer Institute
    Bethesda, USA
  • Daniela Rhodes, PhD, FRS
    Emeritus Research Leader, LMB Division of Structural Studies
    MRC Laboratory of Molecular Biology
    Cambridge, United Kingdom
  • Josep Tabernero, MD PhD
    Director, Vall d’Hebron Institute of Oncology (VHIO)
    Head, Medical Oncology Department of Vall d’Hebron University Hospital
    Barcelona, Spain
  • Subir